QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

This Article
* Abstract Freely available
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Web of Science (69)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Lichtenberg, F. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Lichtenberg, F. R.
Related Collections
* Pharmaceuticals
* Health Spending

Are The Benefits Of Newer Drugs Worth Their Cost? Evidence From The 1996 MEPS

Frank R. Lichtenberg


Figure 1
View larger version (12K):

[in a new window]
 
EXHIBIT 2 Frequency Distribution Of MEPS Prescriptions, By Date Active Ingredient Was Approved, 1996

 

Figure 2
View larger version (17K):

[in a new window]
 
EXHIBIT 4 Distribution Of Persons In MEPS Sample, By Number Of Reported Medical Conditions, 1996

 


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2001 Project HOPE–The People-to-People Organization
Terms and Policies